PillSorted valuation, funding and investors

pillsorted.com ↗LinkedIn ↗

PillSorted works in pharmacy services, based in Cambridge, United Kingdom. Founded in 2019, it has about 24 employees.

Seed

VALUATION · TODAY

$8.95M −8% after Seed

Range $2.47M – $68.4M · Grade D

TODAY

+12 MO

$50.0M

$100M

$150M

2020

2021

2022

2023

2024

2025

2026

2027

Seed $6.00M

ValuationBefore first round12-month outlook: where it points, how wide it fansHover the past: the outlook shows what was predicted then

HEADCOUNT · TODAY24 employees

−25%6m growth

−20%1y growth

+0%2y growth

Data from Jan 2021

TODAY

Predicted in 1 yr $8.28M −8% vs today

Predicted next raise $12.0M if a round comes

Winding-down probability 97%

Last round: Seed · $6.00M · Apr 2022
Valuation at last round: $30.6M · implied
Headcount: 24 · down
Grade: D
Founded: 2019

How VCMC values companies →

PillSorted valuation today

VCMC values PillSorted at $8.95M today, with a range of $2.47M to $68.4M and a grade of D. The valuation starts from its last funding round, a seed round in Apr 2022.

Valuation by date (96 rows)

Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.

PillSorted: valuation by date, as the model would have shown it on each date
Date	Valuation	Range	Predicted in 1 yr	Phase	Headcount	Trend	Grade	Winding-down probability
1 Jan 2019	$7.58M	$2.76M – $20.8M	$9.37M (+24%)	before first round	–	unknown	D	0%
1 Feb 2019	$7.79M	$2.84M – $21.4M	$9.45M (+21%)	before first round	–	unknown	D	0%
1 Mar 2019	$7.98M	$2.90M – $21.9M	$9.53M (+19%)	before first round	–	unknown	D	0%
1 Apr 2019	$8.19M	$2.98M – $22.5M	$9.62M (+17%)	before first round	–	unknown	D	0%
1 May 2019	$8.41M	$3.06M – $23.1M	$9.71M (+15%)	before first round	–	unknown	D	0%
1 Jun 2019	$8.64M	$3.14M – $23.7M	$9.80M (+13%)	before first round	–	unknown	D	0%
1 Jul 2019	$8.87M	$3.23M – $24.4M	$9.88M (+11%)	before first round	–	unknown	D	0%
1 Aug 2019	$8.95M	$3.26M – $24.6M	$9.97M (+11%)	before first round	–	unknown	D	0%
1 Sep 2019	$9.04M	$3.29M – $24.8M	$10.1M (+11%)	before first round	–	unknown	D	0%
1 Oct 2019	$9.12M	$3.32M – $25.0M	$10.2M (+11%)	before first round	–	unknown	D	0%
1 Nov 2019	$9.20M	$3.35M – $25.3M	$10.2M (+11%)	before first round	–	unknown	D	0%
1 Dec 2019	$9.28M	$3.38M – $25.5M	$10.3M (+11%)	before first round	–	unknown	D	0%
1 Jan 2020	$9.37M	$3.41M – $25.7M	$10.4M (+11%)	before first round	–	unknown	D	0%
1 Feb 2020	$9.45M	$3.44M – $26.0M	$10.5M (+11%)	before first round	–	unknown	D	0%
1 Mar 2020	$9.54M	$3.47M – $26.2M	$10.6M (+11%)	before first round	–	unknown	D	0%
1 Apr 2020	$9.62M	$3.50M – $26.4M	$10.7M (+11%)	before first round	–	unknown	D	0%
1 May 2020	$9.71M	$3.53M – $26.7M	$10.8M (+11%)	before first round	–	unknown	D	0%
1 Jun 2020	$9.80M	$3.57M – $26.9M	$10.9M (+11%)	before first round	–	unknown	D	0%
1 Jul 2020	$9.89M	$3.60M – $27.2M	$11.0M (+11%)	before first round	–	unknown	D	0%
1 Aug 2020	$9.98M	$3.63M – $27.4M	$11.1M (+11%)	before first round	–	unknown	D	0%
1 Sep 2020	$10.1M	$3.67M – $27.7M	$11.2M (+11%)	before first round	–	unknown	D	0%
1 Oct 2020	$10.2M	$3.70M – $27.9M	$11.3M (+11%)	before first round	–	unknown	D	0%
1 Nov 2020	$10.3M	$3.73M – $28.2M	$11.4M (+11%)	before first round	–	unknown	D	0%
1 Dec 2020	$10.3M	$3.76M – $28.4M	$11.5M (+11%)	before first round	–	unknown	D	0%
1 Jan 2021	$7.47M	$2.72M – $20.5M	$8.31M (+11%)	before first round	2	unknown	D	0%
1 Feb 2021	$7.53M	$2.74M – $20.7M	$8.38M (+11%)	before first round	2	unknown	D	0%
1 Mar 2021	$7.60M	$2.77M – $20.9M	$8.43M (+11%)	before first round	2	unknown	D	0%
1 Apr 2021	$7.67M	$2.79M – $21.1M	$8.50M (+11%)	before first round	2	unknown	D	0%
1 May 2021	$7.73M	$2.82M – $21.2M	$8.56M (+11%)	before first round	2	unknown	D	0%
1 Jun 2021	$7.81M	$2.84M – $21.4M	$8.62M (+10%)	before first round	2	unknown	D	0%
1 Jul 2021	$7.87M	$2.87M – $21.6M	$8.69M (+10%)	before first round	2	unknown	D	0%
1 Aug 2021	$7.95M	$2.89M – $21.8M	$8.75M (+10%)	before first round	2	unknown	D	0%
1 Sep 2021	$8.02M	$2.92M – $22.0M	$8.82M (+10%)	before first round	2	unknown	D	0%
1 Oct 2021	$8.09M	$2.95M – $22.2M	$8.88M (+10%)	before first round	2	unknown	D	0%
1 Nov 2021	$8.17M	$2.97M – $22.4M	$8.95M (+10%)	before first round	2	unknown	D	0%
1 Dec 2021	$8.24M	$3.00M – $22.6M	$9.01M (+9%)	before first round	2	unknown	D	0%
1 Jan 2022	$8.31M	$3.03M – $22.8M	$9.08M (+9%)	before first round	2	unknown	D	0%
1 Feb 2022	$8.38M	$3.05M – $23.0M	$9.15M (+9%)	before first round	2	unknown	D	0%
1 Mar 2022	$8.43M	$3.07M – $23.2M	$9.21M (+9%)	before first round	2	unknown	D	0%
1 Apr 2022	$8.50M	$3.09M – $23.3M	$9.28M (+9%)	before first round	2	unknown	D	0%
28 Apr 2022	$30.6M	$20.1M – $93.1M	$61.2M (+100%)	after a round	2	unknown	C	0%
1 May 2022	$30.8M	$20.1M – $93.1M	$61.2M (+98%)	after a round	2	unknown	C	0%
1 Jun 2022	$32.7M	$20.1M – $93.1M	$61.2M (+87%)	after a round	2	unknown	C	0%
1 Jul 2022	$34.6M	$20.1M – $93.1M	$61.2M (+77%)	after a round	2	unknown	C	0%
1 Aug 2022	$36.7M	$20.1M – $93.1M	$61.2M (+67%)	after a round	2	unknown	C	0%
1 Sep 2022	$38.9M	$20.1M – $93.1M	$61.2M (+57%)	after a round	2	unknown	C	0%
1 Oct 2022	$41.2M	$20.1M – $93.1M	$61.2M (+48%)	after a round	2	unknown	C	0%
1 Nov 2022	$43.7M	$20.1M – $93.1M	$61.2M (+40%)	after a round	2	unknown	C	0%
1 Dec 2022	$46.3M	$20.1M – $93.1M	$61.2M (+32%)	after a round	30	unknown	C	0%
1 Jan 2023	$49.1M	$20.1M – $93.1M	$61.2M (+25%)	after a round	30	unknown	C	0%
1 Feb 2023	$52.0M	$20.1M – $93.1M	$61.2M (+18%)	after a round	30	unknown	C	0%
1 Mar 2023	$54.9M	$20.1M – $93.1M	$61.2M (+11%)	after a round	30	unknown	C	0%
1 Apr 2023	$58.2M	$20.1M – $93.1M	$61.2M (+5%)	after a round	30	unknown	C	0%
1 May 2023	$61.2M	$20.0M – $93.1M	$61.2M (0%)	after a round	30	unknown	C	0%
1 Jun 2023	$61.2M	$19.0M – $93.1M	$61.2M (0%)	after a round	30	unknown	C	0%
1 Jul 2023	$61.2M	$18.1M – $93.1M	$61.2M (0%)	after a round	30	unknown	C	0%
1 Aug 2023	$61.2M	$17.2M – $93.1M	$61.2M (0%)	after a round	30	unknown	C	0%
1 Sep 2023	$61.2M	$16.3M – $93.1M	$61.2M (0%)	after a round	30	unknown	C	0%
1 Oct 2023	$61.2M	$15.5M – $93.1M	$61.2M (0%)	after a round	30	unknown	C	0%
1 Nov 2023	$26.5M	$14.8M – $55.7M	$16.8M (-37%)	after a round	24	down	C	97%
1 Dec 2023	$25.8M	$14.1M – $57.1M	$16.2M (-37%)	after a round	24	down	C	97%
1 Jan 2024	$25.1M	$13.4M – $58.6M	$15.7M (-38%)	after a round	24	down	C	97%
1 Feb 2024	$24.5M	$12.7M – $60.2M	$15.2M (-38%)	after a round	24	down	C	97%
1 Mar 2024	$23.9M	$12.1M – $61.6M	$14.7M (-39%)	after a round	23	down	C	97%
1 Apr 2024	$20.1M	$11.5M – $41.4M	$11.3M (-44%)	after a round	22	shrinking	C	97%
1 May 2024	$18.3M	$10.9M – $33.2M	$10.8M (-41%)	after a round	22	shrinking	B	97%
1 Jun 2024	$17.5M	$10.4M – $32.2M	$10.3M (-41%)	after a round	22	shrinking	B	97%
1 Jul 2024	$21.1M	$9.90M – $53.4M	$14.3M (-33%)	after a round	22	flat	C	89%
1 Aug 2024	$22.3M	$9.41M – $56.1M	$15.4M (-31%)	after a round	22	flat	C	82%
1 Sep 2024	$23.6M	$8.94M – $58.6M	$16.6M (-29%)	after a round	24	flat	C	76%
1 Oct 2024	$24.8M	$8.51M – $61.0M	$17.9M (-28%)	after a round	24	flat	C	70%
1 Nov 2024	$26.1M	$8.09M – $63.3M	$19.1M (-27%)	after a round	24	flat	D	64%
1 Dec 2024	$27.4M	$7.70M – $65.5M	$20.3M (-26%)	after a round	23	flat	D	59%
1 Jan 2025	$28.6M	$7.32M – $67.5M	$21.5M (-25%)	after a round	23	flat	D	54%
1 Feb 2025	$29.9M	$6.96M – $69.5M	$22.6M (-24%)	after a round	23	flat	D	50%
1 Mar 2025	$31.2M	$6.64M – $71.3M	$23.9M (-23%)	after a round	23	flat	D	46%
1 Apr 2025	$32.4M	$6.31M – $73.0M	$25.0M (-23%)	after a round	23	flat	D	42%
1 May 2025	$33.5M	$6.01M – $74.0M	$27.5M (-18%)	after a round	23	flat	D	39%
1 Jun 2025	$34.5M	$5.71M – $74.6M	$28.6M (-17%)	after a round	23	flat	D	36%
1 Jul 2025	$35.4M	$5.44M – $75.1M	$29.6M (-16%)	after a round	23	flat	D	33%
1 Aug 2025	$36.8M	$5.88M – $76.5M	$32.5M (-12%)	after a round	29	up	D	30%
1 Sep 2025	$38.0M	$11.8M – $77.6M	$34.4M (-9%)	after a round	30	growing	C	28%
1 Oct 2025	$38.9M	$5.40M – $78.1M	$35.1M (-10%)	after a round	30	up	D	26%
1 Nov 2025	$40.1M	$5.17M – $79.2M	$36.9M (-8%)	after a round	32	up	D	24%
1 Dec 2025	$41.1M	$11.7M – $80.0M	$38.1M (-7%)	after a round	33	growing	C	22%
1 Jan 2026	$42.1M	$11.7M – $80.7M	$39.3M (-7%)	after a round	33	growing	C	20%
1 Feb 2026	$43.0M	$4.55M – $81.4M	$40.4M (-6%)	after a round	32	up	D	18%
1 Mar 2026	$44.0M	$11.6M – $82.1M	$41.5M (-6%)	after a round	32	growing	C	17%
1 Apr 2026	$44.9M	$11.5M – $82.7M	$42.8M (-5%)	after a round	32	growing	C	16%
1 May 2026	$46.5M	$12.4M – $87.6M	$44.1M (-5%)	after a round	32	growing	C	14%
1 Jun 2026	$38.1M	$3.14M – $78.3M	$32.9M (-14%)	after a round	28	flat	D	20%
1 Jul 2026	$37.6M	$2.99M – $77.6M	$32.6M (-13%)	after a round	28	flat	D	20%
1 Aug 2026	$11.9M	$2.84M – $63.5M	$9.48M (-21%)	after a round	25	down	D	79%
1 Sep 2026	$8.45M	$2.70M – $59.7M	$6.79M (-20%)	after a round	26	down	D	95%
1 Oct 2026	$7.88M	$2.57M – $58.9M	$6.55M (-17%)	after a round	24	down	D	97%
24 Oct 2026	$8.95M	$2.47M – $68.4M	$8.28M (-8%)	after a round	24	down	D	97%

Key facts about PillSorted

Founded: 2019
Headquarters: Cambridge, United Kingdom
Employees: about 24 -25% in a year
Total raised: $6.0M
Funding rounds: 1
Last round: Seed Apr 2022

PillSorted was founded in 2019 by Mohammad Mohaghegh and Zeinab Ardeshir.

PillSorted funding history

PillSorted has 1 funding round on record, from Apr 2022 to Apr 2022, $6.0M in total. None disclosed a valuation.

Seed 27 Apr 2022
Led by Pear VC; with Hoxton Ventures, Edison Partners, DoorDash.
Sources: techfundingnews.com, uktechnews.info, uktech.news and 1 more
$6.0M

PillSorted investors

4 investors have backed PillSorted; Pear VC led at least one round.

DoorDash
Edison Partners
Hoxton Ventures

What PillSorted does

PillSorted works in drug stores & pharmacies, with 15 recorded offerings and customers in healthcare.

PillSorted Limited is a British pharmacy company that operates as a registered pharmacy, NHS-funded provider, and telehealth service. The company offers pharmaceutical services such as prescription management, medication dispensing, and delivery, as well as telehealth consultations for common health conditions. PillSorted also provides medical supply store and women's health clinic services, and delivers weight loss, general health, and sexual health support. Its operations are supported by a team of pharmacists and IT specialists, and the company is certified as an NHS partner.

Description from Veridion's company data.

Products and services

Pharmacy Services
Prescription Medication Management and Dispensing
Home Medication Delivery Services
Telehealth Consultation Services
Tailored Health Care Solutions
NHS Prescription Fulfillment Services
Contraception Services
Weight Loss Support Services
Women’s Health Services
Men’s Health Services
Mental Health Support Services
Pain Management Services
Respiratory and Digestive Health Services
Travel Health Services
Sexual Health Services

Markets

Healthcare

Certifications

GPhC certified
NHS certified

Business model

Business-to-Consumer
Service Provider
Retail

Industry codes (NAICS)

456110 Pharmacies and Drug Retailers 100% match

Questions about PillSorted

What is PillSorted worth?

Valuation $8.95M (range $2.47M to $68.4M), as of 24 Oct 2026.

Has PillSorted raised money?

PillSorted has 1 funding round on record, from Apr 2022 to Apr 2022, $6.0M in total. None disclosed a valuation.

Who has invested in PillSorted?

Pear VC, DoorDash, Edison Partners and Hoxton Ventures. Lead investors include Pear VC.

How many people work at PillSorted?

About 24, down 25% over the last year. Headcount rose from 2 in Jan 2021 to 33 in Nov 2025, then fell to 24 in Sep 2026.

What does PillSorted do?

PillSorted works in drug stores & pharmacies, with 15 recorded offerings and customers in healthcare. Its main offerings are pharmacy services, prescription medication management and dispensing and home medication delivery services.

When was PillSorted founded, and where is it based?

PillSorted was founded in 2019 and is based in Cambridge, United Kingdom. It has about 24 employees, down 25% over the last year.

How we value companies Report an issue